KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inovio Pharmaceuticals (INO) Goodwill & Intangibles (2016 - 2023)

Inovio Pharmaceuticals (INO) has disclosed Goodwill & Intangibles for 14 consecutive years, with $10.5 million as the latest value for Q2 2023.

  • Quarterly Goodwill & Intangibles fell 18.39% to $10.5 million in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $10.5 million through Jun 2023, down 18.39% year-over-year, with the annual reading at $12.6 million for FY2022, 3.78% down from the prior year.
  • Goodwill & Intangibles hit $10.5 million in Q2 2023 for Inovio Pharmaceuticals, down from $12.6 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $15.0 million in Q1 2019 to a low of $10.5 million in Q2 2023.
  • Historically, Goodwill & Intangibles has averaged $13.4 million across 5 years, with a median of $13.5 million in 2021.
  • Biggest YoY gain for Goodwill & Intangibles was 3.47% in 2023; the steepest drop was 18.39% in 2023.
  • Year by year, Goodwill & Intangibles stood at $14.2 million in 2019, then fell by 3.85% to $13.7 million in 2020, then fell by 3.81% to $13.1 million in 2021, then fell by 3.78% to $12.6 million in 2022, then fell by 16.85% to $10.5 million in 2023.
  • Business Quant data shows Goodwill & Intangibles for INO at $10.5 million in Q2 2023, $12.6 million in Q1 2023, and $12.6 million in Q4 2022.